摘要
目的:构建野生型及突变型人IL-13(hIL-13)哺乳细胞表达质粒。方法:采用融合PCR扩增人生长激素(hGH)-hIL13融合蛋白编码序列。PCR产物和pcDNA3.1表达载体经HindⅢ和EcoRⅠ双酶切处理后,将PCR产物定向插入pcDNA3.1真核表达载体中,构建质粒pcDNA3.1(+)/hGH-hIL13-a和pcDNA3.1(+)/hGH-hIL13-g。将其转化到DH5α感受态细胞内进行扩增,阳性克隆鉴定,质粒抽提,进行测序验证。结果:重组质粒pcDNA3.1(+)/hGH-hIL13-a和pcDNA3.1(+)/hGH-hIL13-g经测序验证,hGH-hIL13融合蛋白编码序列与实验设计一致,且已与pcDNA3.1(+)真核表达载体正确重组。结论:成功构建了哺乳细胞表达质粒pcDNA3.1(+)/hGH-hIL13-a和pcDNA3.1(+)/hGH-hIL13-g,为后续野生型及突变型hIL-13哺乳细胞的重组表达奠定了基础。
Objective:To construct the expression plasmids of wild-type and mutant interleukin-13 expression plasmids in mammalian cells.Methods:The hGH-hIL13 fusion protein gene was amplified by fusion PCR.Both the PCR product and the vector pcDNA3.1(+) were digested by the Hind Ⅲ and EcoRⅠ.Then the PCR product was cloned in the eukaryotic expression vector of pcDNA3.1(+).The plasmids were constructed and transformed into E.coli competent cells DH5α.The positive clones were selected,and tested by sequencing.Results:The hGH-hIL13 fusion protein gene was in accordance with the design and correctly inserted into the vector proved by sequencing.Conclusion:The successful construction of the pcDNA3.1(+)/hGH-hIL13-a and pcDNA3.1(+)/hGH-hIL13-g plasmids lays the foundation for the wild-type and mutant interleukin-13 expression in mammalian cells.
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
2011年第11期966-969,共4页
Chinese Journal of Immunology
基金
国家自然科学基金项目资助(30872805
30972750)
上海市科学技术委员会科研计划项目资助(08411953200)